Clinical trial
A Multicenter, Double-blind, Randomized, Parallel Group Study to Assess the Effect of NCX4016 vs Placebo on Walking Distance in Patients With Peripheral Arterial Occlusive Disease at Leriche-Fontaine Stage II
NCT01256775 is registered in ClinicalTrials.gov with NicOx Research Institute S.r.l. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized, Parallel Group Study to Assess the Effect of NCX4016 vs Placebo on Walking Distance in Patients With Peripheral Arterial Occlusive Disease at Leriche-Fontaine Stage II
- Lead sponsor
- NicOx Research Institute S.r.l.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- April 30, 2005
- Enrollment
- 442 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.